Tesaro, Inc. (TSRO) was a big mover last session, as its shares rose over 13% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the uptrend for the company since Jan 6, as the stock is now up 50%.
In the last 30-day frame, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Tesaro currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.
Other better-ranked stocks in the medical sector include Grifols, S.A. (GRFS), Endocyte, Inc. (ECYT) and Lannett Company, Inc. (LCI). All three sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment